127 related articles for article (PubMed ID: 8743819)
1. Lack of p53 immunoreactivity in pancreatic endocrine tumors.
Lee CS
Pathology; 1996 May; 28(2):139-41. PubMed ID: 8743819
[TBL] [Abstract][Full Text] [Related]
2. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.
Canavese G; Azzoni C; Pizzi S; Corleto VD; Pasquali C; Davoli C; Crafa P; Delle Fave G; Bordi C
Hum Pathol; 2001 Oct; 32(10):1094-101. PubMed ID: 11679944
[TBL] [Abstract][Full Text] [Related]
3. Anatomic distribution of pancreatic endocrine tumors.
Howard TJ; Stabile BE; Zinner MJ; Chang S; Bhagavan BS; Passaro E
Am J Surg; 1990 Feb; 159(2):258-64. PubMed ID: 2154144
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin and glucagonoma.
Philippe J; Powers AC; Brand SJ
N Engl J Med; 1988 Jan; 318(2):121-2. PubMed ID: 2827024
[No Abstract] [Full Text] [Related]
5. Immunohistochemical demonstration of the p53 tumour suppressor gene product in cancer of the pancreas and chronic pancreatitis.
Lee CS; Rush M; Charalambous D; Rode J
J Gastroenterol Hepatol; 1993; 8(5):465-9. PubMed ID: 8218996
[TBL] [Abstract][Full Text] [Related]
6. [Pathological anatomy of neoplasms of the pancreas. II. Tumors of the endocrine pancreas].
González Cámpora R; Amérigo Navarro J; Martín Lacave I; Fernández-Novoa MC; Galera H
Rev Esp Oncol; 1982; 29(1):23-47. PubMed ID: 6322253
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C in the human pancreas and gut: an immunohistochemical study of normal and neoplastic tissues.
Lignelid H; Jacobsson B
Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):491-5. PubMed ID: 1466152
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies as probes to the differentiated exocrine pancreas react to monoclonal islet tumor tissue.
Beck TC; Madsen OD
Exp Clin Endocrinol; 1989 May; 93(2-3):255-60. PubMed ID: 2550269
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
Hepatogastroenterology; 2000; 47(33):875-9. PubMed ID: 10919051
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I.
Iwakura H; Hosoda K; Doi R; Komoto I; Nishimura H; Son C; Fujikura J; Tomita T; Takaya K; Ogawa Y; Hayashi T; Inoue G; Akamizu T; Hosoda H; Kojima M; Kangawa K; Imamura M; Nakao K
J Clin Endocrinol Metab; 2002 Nov; 87(11):4885-8. PubMed ID: 12414844
[TBL] [Abstract][Full Text] [Related]
12. Primary endocrine-secreting pancreatic tumors.
Macaron C
Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
[TBL] [Abstract][Full Text] [Related]
13. Endocrine tumors of the pancreas: the pathologist's approach.
Bordi C
Acta Biomed Ateneo Parmense; 1993; 64(5-6):195-204. PubMed ID: 7992557
[TBL] [Abstract][Full Text] [Related]
14. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas.
Graeme-Cook F; Nardi G; Compton CC
Am J Clin Pathol; 1990 Feb; 93(2):273-6. PubMed ID: 1689098
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic endocrine tumors.
Klöppel G; Heitz PU
Pathol Res Pract; 1988 Apr; 183(2):155-68. PubMed ID: 2898775
[TBL] [Abstract][Full Text] [Related]
17. Endocrine tumours of the pancreas: an update.
Proye CA
Aust N Z J Surg; 1998 Feb; 68(2):90-100. PubMed ID: 9493997
[No Abstract] [Full Text] [Related]
18. Role of p53 tumor suppressor gene in pancreatic endocrine tumors of Chinese patients.
Lam KY; Lo CY
Am J Gastroenterol; 1998 Aug; 93(8):1232-5. PubMed ID: 9707043
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness.
Yokoyama M; Yamanaka Y; Friess H; Buchler M; Korc M
Anticancer Res; 1994; 14(6B):2477-83. PubMed ID: 7872670
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical patterns of islet cell tumors as defined by the monoclonal antibody HISL-19.
Bordi C; Krisch K; Horvat G; Srikanta S
Am J Pathol; 1988 Aug; 132(2):249-57. PubMed ID: 2840831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
